Related Experiment Video
Updated: Aug 8, 2026

Specific Marking of HIV-1 Positive Cells using a Rev-dependent Lentiviral Vector Expressing the Green Fluorescent Protein
Published on: September 24, 2010
Detection of intracellular HIV-1 Rev protein by flow cytometry
Insights
Researchers developed a flow cytometry assay to quantify human immunodeficiency virus type 1 (HIV-1) Rev protein levels. This method aids HIV research and gene therapy by measuring Rev wild type and RevM10 proteins in infected cells.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- The Rev trans-activator protein is crucial for human immunodeficiency virus type 1 (HIV-1) replication, regulating viral structural protein expression.
- Accurate quantification of intracellular Rev protein levels is essential for understanding HIV-1 pathogenesis and developing therapeutic strategies.
Purpose of the Study:
- To develop and validate a quantitative flow cytometry assay for intracellular steady-state levels of HIV-1 Rev proteins (wild type and RevM10).
- To compare different fixation and permeabilization techniques for optimizing Rev protein detection.
- To assess the applicability of the assay for various cell types and HIV-1 infection models.
Main Methods:
- Quantitative flow cytometry assay development.
- Comparison of three distinct fixation and permeabilization protocols.
- Detection of intracellular Rev wild type and RevM10 proteins.
- Detection of HIV-Tat protein as a secondary validation.
Main Results:
- The developed flow cytometry assay effectively quantifies intracellular Rev protein levels.
- Different fixation and permeabilization methods impact signal magnitude and population discrimination.
- The assay is applicable to diverse cell types, including primary cells and cell lines, infected with HIV-1.
- The assay successfully detected a second intracellular protein, HIV-Tat.
Conclusions:
- A robust flow cytometry assay for quantifying intracellular HIV-1 Rev proteins has been established.
- This assay is a valuable tool for analyzing Rev expression in HIV-infected cells.
- The assay can aid in optimizing the delivery of the RevM10 gene for gene therapy applications in HIV-1 treatment.
Abstract:
The Rev trans-activator protein plays a pivotal role in human immunodeficiency virus type 1 (HIV-1) replication by allowing expression of the viral structural proteins. We have developed a protocol to quantitatively assay intracellular steady state levels of Rev Ag (Rev wild type and RevM10 proteins) by flow cytometry. Three fixation and permeabilization techniques were compared. These protocols varied in the magnitude of the signal which could be detected, and in the ability to distinguish between Rev Ag positive and negative populations. This technology is applicable to a variety transduced or transfected cell types (species, lineage), and for cell lines and primary cells acutely infected with HIV-1. The assay is therefore a valuable tool both to analyze Rev protein expression levels in HIV-infected cells and to optimize delivery of the dominant-negative RevM10 gene for clinical gene therapy applications. In addition, a second, independent intracellular protein (HIV-Tat) has been detected using the same approach.

